[Federal Register: December 1, 2006 (Volume 71, Number 231)]
[Notices]               
[Page 69589]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01de06-101]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances; Notice of Registration

    By Notice dated August 15, 2006 and published in the Federal 
Register on August 22, 2006, (71 FR 48946-48947), Almac Clinical 
Services Incorporated (ACSI) formerly known as Clinical Trial Services, 
2661 Audubon Road, Audubon, Pennsylvania 19403, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of the basic classes of controlled substances listed in 
schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to import small quantities of the listed 
controlled substances in dosage form to conduct clinical trials.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and Sec.  952(a) and determined that 
the registration of Almac Clinical Services Incorporation (ACSI) to 
import the basic classes of controlled substances is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971, at this time. DEA has investigated Almac Clinical Services 
Incorporation (ACSI) to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, 
the above named company is granted registration as an importer of the 
basic classes of controlled substances listed.

     Dated: November 21, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-20337 Filed 11-30-06; 8:45 am]

BILLING CODE 4410-09-P